Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: A randomized controlled trial

Academic Emergency Medicine

Volumn 11, Issue 12, 2004, Pages 1278-1282

  Lovell, Stephanie J ^a   Taira, Taku ^a   Rodriguez, Erica ^a   Wackett, Andrew ^a   Gulla, Janet ^a   Singer, Adam J ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

COX 2 inhibitor; oxycodone; pain; valdecoxib

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; OXYCODONE; PARACETAMOL; VALDECOXIB;

ACUTE DISEASE; ADULT; ANALGESIA; ANALYSIS OF VARIANCE; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUSCULOSKELETAL DISEASE; NAUSEA; NECK PAIN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SIDE EFFECT; STUDENT T TEST; TELEPHONE; TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; URBAN AREA; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ACUTE DISEASE; ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EMERGENCY MEDICINE; FEMALE; HUMANS; ISOXAZOLES; MALE; MUSCULOSKELETAL DISEASES; OXYCODONE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 9644295755     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2004.06.011     Document Type: Article

References (16)

1. Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma: Clinical Practice Guideline. Rockville, MD: Public Health Service, U.S. Department of Health and Human Services, February 1992. Agency for Health Care Policy and Research, publication 92-0032.
2. L.F. McCaig, and C.W. Burt National Hospital Ambulatory Medical Care Survey: 2001 Emergency Department Summary. Advance Data from Vital Statistics; no. 335 2003 National Center for Health Statistics Hyattsville, MD
3. M.L. Chavez, and C.J. DeKortie Valdecoxib: a review Clin Ther 25 2003 817 851
4. S.L. Wallenstein Scaling clinical pain and pain relief B. Broman Pain Measurement in Man: Neuropsychological Correlates of Pain 1984 Elsevier Science New York 389 396
5. J. Cohen Statistical Power Analysis for the Behavioral Sciences 1988 Lawrence Erlbaum Associates Hillsdale, NJ
6. K.H. Todd, K.G. Funk, and J.P. Funk Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
7. J.P. Funk, and K. Todd The minimum clinically important difference in physician assigned visual analog pain scores Acad Emerg Med 3 1996 142 146
8. J.J. Talley, D.L. Brown, and J.S. Carter 4-5-Methyl-3-pheniylisoxazol-4- yl-benzenesulfunamide valdecoxib: a potent and selective inhibitor of COX-2 J Med Chem 43 2000 775 777
9. W. Bensen, L. Weaver, and L. Espinoza Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen Rheumatology 41 2002 1008 1016
10. S.A. Jagtap, S. Lahoti, K. Anwaruddin, S. Ram, C. Ballary, and A. Desai Evaluation of efficacy and tolerability of valdecoxib in osteoarthritis patients J Indian Med Assoc 100 2002 673 674
11. S.E. Daniels, S. Talwalker, S. Torri, M.C. Snabes, D.P. Recker, and K.M. Verburg Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea Obstet Gynecol 100 2001 350 358
12. L.W. Reynolds, R.K. Hoo, R.J. Brill, J. North, D.P. Recker, and K.M. Verburg The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty J Pain Symptom Manage 25 2003 133 141
13. S.E. Daniels, P.J. Desjardins, S. Talwalker, D.P. Recker, and K.M. Verburg The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery J Am Dent Assoc 133 2002 611 621
14. J. Fricke, J. Varkalis, and S. Zwillich Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery Am J Ther 9 2002 89 97
15. P. Leese, S. Talwalker, and D. Recker Valdecoxib, a novel COX-2 specific inhibitor, does not impair platelet function in healthy adults: results of a randomized controlled trial Am J Emerg Med 20 2002 275 281
16. D.H. Sikes, N.M. Agrawal, W.W. Zhao, J.D. Kent, D.P. Recker, and K.M. Verburg Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with OA Eur J Gastroenterol Hepatol 14 2002 1101 1111